Cardiac toxicity after allo-HCT
| . | Overall N = 585 . | PTCy n = 272 . | Non-PTCy n = 313 . | P . |
|---|---|---|---|---|
| Incidence of cardiac toxicities (Day +100) (%) 95% CI | 6.5 (5-9) | 7.4 (4.7-10.9) | 5.8 (3.5-8.7) | .4 |
| Patients with cardiac toxicity, n | 38 | 20 | 18 | — |
| Episodes/patients, n (%) 1 ≥2 | 24 (63) 14 (37) | 11 (55) 9 (45) | 13 (72) 5 (28) | .3 |
| Type of cardiac toxicity, n (%) Arrhythmia Heart failure Myocardial infarction or ischemia Pericardial effusion | n = 52 21 (40) 14 (27) 7 (13) 10 (19) | n = 29 13 (45) 8 (28) 4 (14) 4 (14) | n = 23 8 (35) 6 (26) 3 (13) 6 (26) | .5 .9 .6 .2 |
| . | Overall N = 585 . | PTCy n = 272 . | Non-PTCy n = 313 . | P . |
|---|---|---|---|---|
| Incidence of cardiac toxicities (Day +100) (%) 95% CI | 6.5 (5-9) | 7.4 (4.7-10.9) | 5.8 (3.5-8.7) | .4 |
| Patients with cardiac toxicity, n | 38 | 20 | 18 | — |
| Episodes/patients, n (%) 1 ≥2 | 24 (63) 14 (37) | 11 (55) 9 (45) | 13 (72) 5 (28) | .3 |
| Type of cardiac toxicity, n (%) Arrhythmia Heart failure Myocardial infarction or ischemia Pericardial effusion | n = 52 21 (40) 14 (27) 7 (13) 10 (19) | n = 29 13 (45) 8 (28) 4 (14) 4 (14) | n = 23 8 (35) 6 (26) 3 (13) 6 (26) | .5 .9 .6 .2 |